Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BCG Vaccine

Known as: Calmette's Vaccine, Bacillus Calmette Guerin, Bacillius Calmette-Guerin Vaccine 
A vaccine containing bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis, with non-specific immunoadjuvant and… Expand
National Institutes of Health

Related topics

Related topics

29 relations

Narrower (3)

BCG, Live, Connaught Strainmethanol extraction residue (MER) tubercle bacillus fractionrBCG85C vaccine
BCG, Live, Tice StrainBCG, Live, Tice Strain 50 MG InjectionBCG, Live, Tice Strain 50 MG/ML Topical Suspension [Tice BCG]BCG/bropirimine
Expand

Broader (2)

Immunologic AdjuvantsTuberculosis Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.
CONTEXT Bacillus Calmette-Guérin (BCG) is currently the most effective intravesical therapy for nonmuscle invasive bladder cancer… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
Review
2017
Review
2017
What Have We Learnt about BCG Vaccination in the Last 20 Years?
A number of new tuberculosis (TB) vaccines have been or are entering clinical trials, which include genetically modified… Expand
Is this relevant?
Review
2017
Review
2017
The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
The only licensed vaccine against tuberculosis (TB), bacille Calmette-Guérin (BCG), protects against severe extrapulmonary forms… Expand
Is this relevant?
Review
2017
Review
2017
Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
BACKGROUND Molecular characterization of nonmuscle invasive bladder cancer (NMIBC) may provide a biologic rationale for treatment… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Review
2017
Review
2017
Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of morbidity and mortality worldwide… Expand
Is this relevant?
Review
2016
Review
2016
Inequalities in full immunization coverage: trends in low- and middle-income countries
OBJECTIVE To investigate disparities in full immunization coverage across and within 86 low- and middle-income countries… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2016
Review
2016
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
OBJECTIVES  To evaluate the effects on non-specific and all cause mortality, in children under 5, of Bacillus Calmette-Guérin… Expand
  • figure 1
  • figure 5
  • figure 6
  • figure 7
  • figure 8
Is this relevant?
Review
2015
Review
2015
Factors influencing full immunization coverage among 12–23 months of age children in Ethiopia: evidence from the national demographic and health survey in 2011
BackgroundImmunization remains one of the most important public health interventions to reduce child morbidity and mortality. The… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Comparative genomics of BCG vaccines by whole-genome DNA microarray.
Bacille Calmette-Guérin (BCG) vaccines are live attenuated strains of Mycobacterium bovis administered to prevent tuberculosis… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
New use of BCG for recombinant vaccines
BCG, a live attenuated tubercle bacillus, is the most widely used vaccine in the world and is also a useful vaccine vehicle for… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE